A detailed history of Wells Fargo & Company transactions in Agenus Inc stock. As of the latest transaction made, Wells Fargo & Company holds 970,150 shares of AGEN stock, worth $16.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
970,150
Previous 1,011,252 4.06%
Holding current value
$16.2 Million
Previous $839,000 33.02%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$0.53 - $0.93 $21,784 - $38,224
-41,102 Reduced 4.06%
970,150 $562,000
Q4 2023

Feb 09, 2024

SELL
$0.63 - $1.14 $809,456 - $1.46 Million
-1,284,851 Reduced 55.96%
1,011,252 $839,000
Q3 2023

Nov 13, 2023

SELL
$1.12 - $1.88 $47,094 - $79,052
-42,049 Reduced 1.8%
2,296,103 $2.59 Million
Q2 2023

Aug 15, 2023

BUY
$1.31 - $2.04 $455,713 - $709,660
347,873 Added 17.48%
2,338,152 $3.74 Million
Q1 2023

May 12, 2023

BUY
$1.45 - $2.95 $1.04 Million - $2.12 Million
719,580 Added 56.63%
1,990,279 $3.03 Million
Q4 2022

Feb 13, 2023

SELL
$2.02 - $3.25 $130,197 - $209,475
-64,454 Reduced 4.83%
1,270,699 $3.05 Million
Q3 2022

Nov 14, 2022

SELL
$1.96 - $3.14 $118,084 - $189,175
-60,247 Reduced 4.32%
1,335,153 $2.74 Million
Q2 2022

Aug 12, 2022

BUY
$1.3 - $2.64 $280,868 - $570,379
216,053 Added 18.32%
1,395,400 $2.71 Million
Q1 2022

May 16, 2022

BUY
$2.35 - $3.47 $309,180 - $456,534
131,566 Added 12.56%
1,179,347 $2.9 Million
Q4 2021

Feb 14, 2022

SELL
$2.92 - $5.74 $200,636 - $394,401
-68,711 Reduced 6.15%
1,047,781 $3.37 Million
Q3 2021

Nov 15, 2021

BUY
$4.98 - $6.63 $206,201 - $274,521
41,406 Added 3.85%
1,116,492 $5.86 Million
Q2 2021

Aug 16, 2021

BUY
$2.56 - $5.49 $67,025 - $143,739
26,182 Added 2.5%
1,075,086 $5.9 Million
Q1 2021

May 13, 2021

SELL
$2.69 - $5.25 $322,743 - $629,889
-119,979 Reduced 10.26%
1,048,904 $2.85 Million
Q4 2020

Feb 09, 2021

SELL
$3.17 - $4.49 $104,254 - $147,667
-32,888 Reduced 2.74%
1,168,883 $3.72 Million
Q3 2020

Nov 05, 2020

SELL
$2.98 - $5.2 $80,758 - $140,920
-27,100 Reduced 2.21%
1,201,771 $4.81 Million
Q2 2020

Aug 13, 2020

BUY
$2.29 - $4.24 $231,232 - $428,134
100,975 Added 8.95%
1,228,871 $4.83 Million
Q1 2020

May 14, 2020

BUY
$1.92 - $4.39 $2.17 Million - $4.95 Million
1,127,896 New
1,127,896 $2.76 Million

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.